KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 129 filers reported holding KYMERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $15,576,000 | -23.0% | 368,061 | +15.5% | 2.20% | -1.0% |
Q4 2021 | $20,232,000 | -4.1% | 318,667 | -11.3% | 2.22% | +25.4% |
Q3 2021 | $21,103,000 | +67.4% | 359,260 | +38.2% | 1.77% | +107.9% |
Q2 2021 | $12,605,000 | +31.0% | 259,895 | +5.0% | 0.85% | +15.6% |
Q1 2021 | $9,619,000 | +5.0% | 247,527 | +67.6% | 0.74% | -9.2% |
Q4 2020 | $9,157,000 | +77.1% | 147,700 | -7.7% | 0.81% | +60.0% |
Q3 2020 | $5,170,000 | – | 160,000 | – | 0.51% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |